Scientific Papers

Identification of novel pathogenic variants of Calpain-3 gene in limb girdle muscular dystrophy R1 | Orphanet Journal of Rare Diseases

Description of Image

  • Murphy AP, Straub V. The classification, natural history and treatment of the limb girdle muscular dystrophies. J Neuromuscul Dis. 2015;2:S7–19. https://doi.org/10.3233/jnd-150105.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bushby KM, ENMC Consortium on Limb-Girdle Dystrophies. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the. Neuromuscul Disord. 1995;5:71–4. https://doi.org/10.1016/0960-8966(93)e0006-g.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Van der Kooi AJ, Barth PG, Busch HF, de Haan R, Ginjaar HB, Van Essen AJ, Van Hooff LJ, Höweler CJ, Jennekens FG, Jongen P, Oosterhuis HJ. The clinical spectrum of limb girdle muscular dystrophy a survey in the Netherlands. Brain. 1996;119:1471–80. https://doi.org/10.1093/brain/119.5.1471.

    Article 
    PubMed 

    Google Scholar
     

  • Mercuri E, Bönnemann CG, Muntoni F. Muscular dystrophies. Lancet. 2019;394:2025–38. https://doi.org/10.1016/s0140-6736(19)32910-1.

    Article 
    PubMed 

    Google Scholar
     

  • Magri F, Del Bo R, D’Angelo MG, Sciacco M, Gandossini S, Govoni A, Napoli L, Ciscato P, Fortunato F, Brighina E, Bonato S. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients. Neuromuscul Disord. 2012;22:934–43. https://doi.org/10.1016/j.nmd.2012.05.001.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Richard I, Hogrel JY, Stockholm D, Payan CA, Fougerousse F, Eymard B, Mignard C, Lopez de Munain A, Fardeau M, Urtizberea JA. Natural history of LGMD 2A for delineating outcome measures in clinical trials. Ann Clin Transl Neurol. 2016;3:248–65. https://doi.org/10.1002/acn3.287.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009;132:3175–86. https://doi.org/10.1093/brain/awp236.

    Article 
    PubMed 

    Google Scholar
     

  • Renjini R, Gayathri N, Nalini A, Bharath MS. Analysis of calpain-3 protein in muscle biopsies of different muscular dystrophies from India. Indian J Med Res. 2012;135:878–86.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Saenz A, Leturcq F, Cobo AM, Poza JJ, Ferrer X, Otaegui D, Camano P, Urtasun M, Vilchez J, Gutierrez-Rivas E, Emparanza J. LGMD2A: genotype–phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain. 2005;128:732–42. https://doi.org/10.1093/brain/awh408.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schessl J, Walter MC, Schreiber G, Schara U, Müller CR, Lochmüller H, Bönnemann CG, Korinthenberg R, Kirschner J. Phenotypic variability in siblings with calpainopathy (LGMD2A). Acta Myol. 2008;27:54–8.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Groen EJ, Charlton R, Barresi R, Anderson LV, Eagle M, Hudson J, Koref MS, Straub V, Bushby KM. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain. 2007;130:3237–49. https://doi.org/10.1093/brain/awm259.

    Article 
    PubMed 

    Google Scholar
     

  • Fanin M, Angelini C. Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: the yield and the pitfalls. Muscle Nerve. 2015;52:163–73. https://doi.org/10.1002/mus.24682.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chae J, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F, Nonaka I. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord. 2001;11:547–55. https://doi.org/10.1016/s0960-8966(01)00197-3.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Vainzof M, De Paula F, Tsanaclis AM, Zatz M. The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A. J Clin Pathol. 2003;56:624–6. https://doi.org/10.1136/jcp.56.8.624.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rosales XQ, Malik V, Sneh A, Chen L, Lewis S, Kota J, Gastier-Foster JM, Astbury C, Pyatt R, Reshmi S, Rodino‐Klapac LR. Impaired regeneration in LGMD2A supported by increased PAX7‐positive satellite cell content and muscle‐specific microrna dysregulation. Muscle Nerve. 2013;47:731–9. https://doi.org/10.1002/mus.23669.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Piluso G, Politano L, Aurino S, Fanin M, Ricci E, Ventriglia VM, Belsito A, Totaro A, Saccone V, Topaloglu H, Nascimbeni AC. Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes. J Med Genet. 2005;42:686–93. https://doi.org/10.1136/jmg.2004.028738.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zheng J, Xu X, Zhang X, Wang X, Shu J, Cai C. Variants of CAPN3 cause limbgirdle muscular dystrophy type 2A in two Chinese families. Exp Ther Med. 2021;21:104–10. https://doi.org/10.3892/etm.2020.9536.

    Article 
    PubMed 

    Google Scholar
     

  • Luo SS, Xi JY, Zhu WH, Zhao CB, Lu JH, Lin J, Wang Y, Lu J, Qiao K. Genetic variability and clinical spectrum of Chinese patients with limb-girdle muscular dystrophy type 2A. Muscle Nerve. 2012;46:723–9. https://doi.org/10.1002/mus.23381.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sorimachi H, Suzuki K. The structure of calpain. J Biochem. 2001;129:653–64. https://doi.org/10.1093/oxfordjournals.jbchem.a002903.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Beckmann JS, Spencer M. Calpain 3, the gatekeeper of proper sarcomere assembly, turnover and maintenance. Neuromuscul Disord. 2008;18:913–21. https://doi.org/10.1016/j.nmd.2008.08.005.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dargelos E, Moyen C, Dedieu S, Veschambre P, Poussard S, Vuillier-Devillers K, Brustis JJ, Cottin P. Development of an inducible system to assess p94 (CAPN3) function in cultured muscle cells. J Biotechnol. 2002;96:271–9. https://doi.org/10.1016/s0168-1656(02)00052-4.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jahnke VE, Peterson JM, Van Der Meulen JH, Boehler J, Uaesoontrachoon K, Johnston HK, Defour A, Phadke A, Yu Q, Jaiswal JK, Nagaraju K. Mitochondrial dysfunction and consequences in calpain-3-deficient muscle. Skelet Muscle. 2020;10:37–53. https://doi.org/10.1186/s13395-020-00254-1.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Park HJ, Jang H, Lee JH, Shin HY, Cho SR, Park KD, Bang D, Lee MG, Kim SM, Lee JH, Choi YC. Clinical and pathological heterogeneity of Korean patients with CAPN3 mutations. Yonsei Med J. 2016;57:173–9. https://doi.org/10.3349/ymj.2016.57.1.173.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Richard I, Roudaut C, Saenz A, Pogue R, Grimbergen JE, Anderson LV, Beley C, Cobo AM, De Diego C, Eymard B, Gallano P. Calpainopathy—a survey of mutations and polymorphisms. Am J Hum Genet. 1999;64:1524–40. https://doi.org/10.1086/302426.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pathak P, Sharma MC, Sarkar C, Jha P, Suri V, Mohd H, Singh S, Bhatia R, Gulati S. (2010) Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation. Neurol India 2010;58:549–554. https://doi.org/10.4103/0028-3886.68675.

  • Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24. https://doi.org/10.1038/gim.2015.30.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chou FL, Angelini C, Daentl D, Garcia C, Greco C, Hausmanowa–Petrusewicz I, Fidzianska A, Wessel H, Hoffman EP. Calpain III mutation analysis of a heterogeneous limb–girdle muscular dystrophy population. Neurology. 1999;52:1015–20. https://doi.org/10.1212/wnl.52.5.1015.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fanin M, Pegoraro E, Matsuda–Asada C, Brown RH, Angelini C. Calpain-3 and dysferlin protein screening in patients with limb–girdle dystrophy and myopathy. Neurology. 2001;56:660–5. https://doi.org/10.1212/wnl.56.5.660.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Luo SS, Xi JY, Lu JH, Zhao CB, Zhu WH, Lin J, Wang Y, Ren HM, Yin B, Andoni UJ. Clinical and pathological features in 15 Chinese patients with calpainopathy. Muscle Nerve. 2011;43:402–9. https://doi.org/10.1002/mus.21908.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fanin M, Nascimbeni AC, Fulizio L, Trevisan CP, Meznaric-Petrusa M, Angelini C. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. Am J Pathol. 2003;163:1929–36. https://doi.org/10.1016/s0002-9440(10)63551-1.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Khadilkar SV, Chaudhari CR, Dastur RS, Gaitonde PS, Yadav JG. Limb-girdle muscular dystrophy in the agarwals: Utility of founder mutations in CAPN3 gene. Ann Indian Acad Neurol. 2016;19:108–11. https://doi.org/10.4103/0972-2327.175435.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ankala A, Kohn JN, Dastur R, Gaitonde P, Khadilkar SV, Hegde MR. Ancestral founder mutations in calpain-3 in the Indian Agarwal community: historical, clinical, and molecular perspective. Muscle Nerve. 2013;47:931–7. https://doi.org/10.1002/mus.23763.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Peddareddygari LR, Surgan V, Grewal RP. Limb-girdle muscular dystrophy type 2A resulting from homozygous G2338C transversion mutation in the calpain-3 gene. J Clin Neuromuscul Dis. 2010;12:62–5. https://doi.org/10.1097/cnd.0b013e3181f3dbd3.

    Article 
    PubMed 

    Google Scholar
     

  • Guglieri M, Magri F, D’Angelo MG, Prelle A, Morandi L, Rodolico C, Cagliani R, Mora M, Fortunato F, Bordoni A, Del Bo R. Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mutat. 2008;29:258–66. https://doi.org/10.1002/humu.20642.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fanin M, Nascimbeni AC, Tasca E, Angelini C. How to tackle the diagnosis of limb-girdle muscular dystrophy 2A. Eur J Hum Genet. 2009;17:598–603. https://doi.org/10.1038/ejhg.2008.193.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Anderson LV, Davison K, Moss JA, Richard I, Fardeau M, Tomé FM, Hübner C, Lasa A, Colomer J, Beckmann JS. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol. 1998;153:1169–79. https://doi.org/10.1016/s0002-9440(10)65661-1.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Haravuori H, Vihola A, Straub V, Auranen M, Richard I, Marchand S, Voit T, Labeit S, Somer H, Peltonen L, Beckmann JS. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology. 2001;56:869–77. https://doi.org/10.1212/wnl.56.7.869.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bevilacqua JA, Guecaimburu Ehuletche MD, Perna A, Dubrovsky A, Franca MC, Vargas S, Hegde M, Claeys KG, Straub V, Daba N, Faria R. The latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and pompe disease. Orphanet J Rare Dis. 2020;15:1–11. https://doi.org/10.1186/s13023-019-1291-2.

    Article 

    Google Scholar
     

  • Description of Image

    Source link